Loading stock data…
AVAH
$6.87+0.23 (+3.46%)
After Hours$7.13+0.26 (+3.78%)· Last close Jun 9
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Aveanna Healthcare Holdings Inc. in the Healthcare sector is trading at $6.87. Wall Street consensus targets $10.05 (10 analysts), implying a +46.3% move over the next 12 months. The stock is currently 33% below its 52-week high of $10.32, remaining 14.0% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +46.3% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 32) — potential for technical mean-reversion
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Anchored to each ticker's own 5-year median trailing P/E, tilted by current ROE and growth. Fair P/E = own median P/E + (ROE × 10) + (max(revenue growth, earnings growth) × 15), capped at ±30% around the historical anchor. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. Premium compounders like COST/MSFT are judged against their own multi-year norm rather than a sector median. Falls back to the sector-anchored formula (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) for recent IPOs and tickers with insufficient history (< 24 monthly samples). Result is a normalised multiple gauge — not a price target.
Current Price$6.87
Potential Downside
0%
Whystock Fair Value$6.87
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus10 analysts
Buy
Mean target$10.05+46.3%
Range$8.00 – $13.00
Fundamentals
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
-
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
108.60%
Volume
Today's trading volume
1.64M
Recent News
4 Outpatient Home Health Stocks Benefiting From Industry Trends
An aging population and rising telehealth and AI adoption boost demand in the Zacks Medical - Outpatient and Home Healthcare industry. DGX, DVA, LFST and AVAH stand to benefit.
Yum! Brands upgraded, Chipotle downgraded: Wall Street's top analyst calls
Yum! Brands upgraded, Chipotle downgraded: Wall Street's top analyst calls
Aveanna Healthcare Raises 2026 Outlook After Family First Deal, Eyes 7%-10% Growth
Aveanna Healthcare (NASDAQ:AVAH) executives outlined the company’s growth strategy, updated 2026 guidance and discussed its newly closed Family First Homecare acquisition during a presentation at William Blair’s Growth Stock Conference. President and CEO Jeff Shaner described Aveanna as a national
Wall Street Analysts Predict a 50.67% Upside in Aveanna (AVAH): Here's What You Should Know
The consensus price target hints at a 50.7% upside potential for Aveanna (AVAH). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Is Aveanna Healthcare (AVAH) One of the Best Cheap Stocks Under $10 to Buy in June?
Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) is one of the best cheap stocks under $10 to buy in June. On May 14, Aveanna Healthcare reported a strong start to 2026, with Q1 revenue reaching $647.9 million, a 15.9% increase year-over-year. Net income rose significantly to $41.7 million, up from $5.2 million in the prior-year period, while […]